Wells Fargo & Company Zomedica Corp. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Zomedica Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 255,001 shares of ZOM stock, worth $28,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
255,001
Previous 105,001
142.86%
Holding current value
$28,050
Previous $14,000
114.29%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ZOM
# of Institutions
95Shares Held
91.7MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.1MShares$5.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.89MShares$1.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.08 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.12MShares$453,2700.0% of portfolio
-
Ubs Group Ag3.94MShares$432,8980.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $108M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...